NY Prosecutors Sue Novartis Over Alleged Kickbacks to Pharmacy

The company is said to have boosted sales of the iron-reduction drug Exjade by giving referrals and rebates to BioScrip
Jan. 9, 2014

Novartis Pharmaceuticals Corp. is accused of offering kickbacks to a specialty pharmacy, BioScrip, in exchange for recommending refills of a blood transfusion drug it produces, according to a complaint filed by state and federal prosecutors in New York. According to New York Attorney General Eric T. Scheniderman, BioScrip agreed to pay $15 million to settle charges that it caused pharmacies to submit tens of thousands of false claims to Medicare and Medicaid. Read the full story

Sign up for our eNewsletters
Get the latest news and updates